Table 3.
Positive impact scale | Positive subscales |
Negative impact scale | Negative subscales |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Altruism/ Empathy | Health Awareness | Meaning of cancer | Positive self-Evaluation | Appearance Concerns | Body Changes | Life interferences | Worry | |||
Country | ||||||||||
USA | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
The Netherlands | −0.25** | −0.32** | −0.25** | −0.05 | −0.23** | 0.16** | 0.18** | 0.13** | 0.08 | 0.13** |
Gender | ||||||||||
Male | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Female | 0.10** | 0.09* | 0.07 | 0.06 | 0.11** | 0.03 | 0.14** | 0.00 | −0.01 | 0.02 |
Age | −0.13** | 0.00 | −0.16** | −0.17** | −0.09 | −0.18** | −0.15** | −0.10* | −0.16** | −0.17** |
Education | ||||||||||
Low | 0.04 | 0.03 | 0.02 | 0.02 | 0.05 | −0.02 | 0.00 | −0.05 | −0.03 | −0.01 |
Medium | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
High | −0.08 | −0.12** | −0.00 | −0.07 | −0.06 | 0.01 | −0.01 | −0.06 | −0.03 | 0.06 |
Marital/partner status | ||||||||||
Partner | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
No partner | 0.02 | 0.05 | 0.06 | −0.04 | 0.01 | 0.06 | 0.02 | 0.05 | 0.01 | 0.08* |
Employment status | ||||||||||
Currently employed | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Not employed/retired | 0.01 | 0.03 | −0.04 | 0.00 | 0.04 | −0.09 | −0.06 | −0.06 | −0.16** | −0.03 |
Years since diagnosis | 0.04 | 0.01 | −0.03 | 0.03 | 0.10* | −0.15** | −0.01 | −0.19** | −0.06 | −0.16** |
NHL histology | ||||||||||
Indolent | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Aggressive | 0.01 | 0.00 | −0.01 | 0.02 | 0.01 | −0.05 | −0.02 | −0.02 | 0.01 | −0.09* |
NHL stage | ||||||||||
I | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
II | 0.09 | 0.09 | 0.07 | 0.07 | 0.05 | 0.09 | 0.05 | 0.05 | 0.06 | 0.10* |
III | 0.08 | 0.05 | 0.08 | 0.08 | 0.05 | 0.12* | 0.08 | 0.10* | 0.10 | 0.10* |
IV | 0.09 | 0.06 | 0.14** | 0.03 | 0.05 | 0.16** | 0.12* | 0.13* | 0.14** | 0.15** |
Chemotherapy | ||||||||||
No | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Yes | 0.09* | 0.08 | 0.01 | 0.05 | 0.16** | 0.05 | 0.02 | 0.13** | 0.03 | 0.01 |
Radiotherapy | ||||||||||
No | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Yes | −0.04 | −0.02 | 0.00 | −0.09 | 0.01 | −0.01 | 0.01 | −0.00 | −0.02 | 0.01 |
Comorbidity | ||||||||||
None | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
1 | −0.03 | −0.03 | −0.05 | −0.01 | −0.02 | 0.09 | 0.07 | 0.10 | 0.08 | 0.07 |
2 | −0.01 | −0.04 | 0.03 | 0.01 | −0.01 | 0.12* | 0.11* | 0.11* | 0.09 | 0.09 |
3 or more | 0.01 | 0.01 | 0.05 | −0.02 | −0.03 | 0.32** | 0.23** | 0.32** | 0.31** | 0.21** |
Note.IOCv2= Impact of Cancer Scale version 2;
p<0.01;
p<.001